Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 3, 2015
Pharmacy Choice - News - U.S. FDA Final Approvals (Drugs & Devices) - July 3, 2015

Pharmacy News

 U.S. FDA Final Approvals (Drugs & Devices)
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
<< Back     Articles(s): 26 - 35 of 35     Go To Page:

6/29/15 - FDA Approves Promacta for New Pediatric Chronic Immune Thrombocytopenia cITP Indication
By a News Reporter-Staff News Editor at Pharma Business Week Ligand Pharmaceuticals Incorporated announces that the FDA has approved a supplemental New Drug Application for the use of Promacta , a Novartis product, for the treatment of children six years and older with chronic immune thrombocytopenia who have had an insufficient response to...
6/29/15 - FDA Approves ZOMIG zolmitriptan Nasal Spray for Migraine in Pediatric Patients Ages 12-17
By a News Reporter-Staff News Editor at Pharma Business Week Impax Specialty Pharma, a division of Impax Laboratories, Inc., announced that the U.S. Food and Drug Administration has approved ZOMIG Nasal Spray for use in pediatric patients 12 years of age and older for the acute treatment of migraine with or without aura. ZOMIG Nasal Spray's appro
6/29/15 - FDA OKs Technology Upgrade for Recipients of First Commercially Available Cochlear Implant [Health & Beauty Close - Up]
Cochlear Limited reported that the U.S. Food and Drug Administration has approved the Cochlear Nucleus 6 Sound Processor for use with the Nucleus 22 Cochlear Implant, giving those who have worn cochlear implants from the beginning access to the latest breakthroughs in true wireless and automatic hearing. "The FDA approval of the Nucleus 6 Sound Pr
6/29/15 - Sanovas Receives FDA Clearance for PulmoVia?
By a News Reporter-Staff News Editor at Pharma Business Week Sanovas, Inc., a rapidly growing life science company, has received FDA 510 Clearance to market its PulmoVia? Working Channel. The PulmoVia is one of several essential tools in the platform of patented technologies Sanovas is developing to improve diagnostic and therapeutic interventi
6/29/15 - TCM cancer treatment enters final trials in US [China Daily: Hong Kong Edition]
The drug, known as Kanglaite Injection, contains anticancer compounds extracted from the seed of coix, a grasslike relative of maize, and has been approved and used as a cancer treatment in China since 1995.. Its inventor, Li Dapeng, has been seeking registration for the drug in the United States. The US Food and Drug Administration gave the go-ahe
6/29/15 - TCM cancer treatment enters final trials in US [China Daily: US Edition]
The drug, known as Kanglaite Injection, contains anticancer compounds extracted from the seed of coix, a grasslike relative of maize, and has been approved and used as a cancer treatment in China since 1995.. Its inventor, Li Dapeng, has been seeking registration for the drug in the United States. The US Food and Drug Administration gave the go-ahe
6/28/15 - Arcadia Biosciences' Gamma-Linolenic Acid Safflower Meal Gets Approval from the U.S. FDA [Professional Services Close - Up]
Arcadia Biosciences recently reported that the U.S. Food and Drug Administration has approved Arcadia's application to amend relevant regulations to permit the use of seed meal from the company's high gamma-linolenic acid safflower seed in animal feed. The company said the FDA concluded that the data provided by Arcadia establishes the safety and..
6/28/15 - The Medicines Company Gets FDA Approval of KENGREAL [Professional Services Close - Up]
The Medicines Company reported the approval of KENGREAL by the U.S. Food and Drug Administration as an adjunctive therapy to percutaneous coronary intervention for reducing periprocedural thrombotic events in patients who have not been treated with a P2Y12 inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor. "The approval of KENGRE
6/28/15 - Torax Medical Gets FDA Approval of a New LINX Device Compatible with 1.5 Tesla MR Systems [Professional Services Close - Up]
According to a media release, the LINX 1.5 T design contains a different grade of magnets that have a higher resistance to being demagnetized when subjected to external magnetic fields. "We are pleased to make this next generation LINX device available to patients seeking relief from their reflux symptoms while broadening their access to diagnosti
6/26/15 - Caldera Medical Announces FDA Clearance for New Generation of Vertessa Lite Polypropylene Mesh for Sacrocolpopexy
Caldera Medical, a medical device company leading the development of innovative abdominally placed products for Pelvic Organ Prolapse, announced the release of an improved Vertessa Lite mesh that is lightweight, flexible and strong for sacrocolpopexy procedures. Vertessa Lite is a large pore, monofilament, polypropylene mesh that is uniquely blu
<< Back     Articles(s): 26 - 35 of 35     Go To Page:


© 2015 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415